Tradestie Institutional Equity Comparison Engine

EW vs BSX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BSX Overall Edge

BSX Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Boston Scientific Corp. (BSX) driven by superior Valuation, Options & Structure while EW counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, EW trades at 31.6x Forward P/E with 28.8% operating margin (+10.5% YoY revenue) versus BSX at 14.2x Forward P/E and 19.6% operating margin (+1.4% YoY). In options structure, EW sits in UNCLASSIFIED (34th %ile IV; Dealer Gamma Walls on Pro) against BSX sits in CONSOLIDATION (53rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner BSX
EW 31.6x vs BSX 14.2x Fwd P/E
Growth & Margin Winner EW
Op Margin 28.8% vs 19.6% ยท YoY +10.5% vs +1.4%
Momentum & Technical Winner EW
1Y +23.9% vs -58.3% ยท 52W Pos 96% vs 6%
Options & Structure Winner BSX
UNCLASSIFIED (34th %ile IV) vs CONSOLIDATION (53rd %ile IV)
EW NYSE
Edwards Lifesciences Corp
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$106.66
-0.46% 1D
Market Cap $60.8B
1M Return +23.16%
1Y Return +23.86%
Forward P/E 31.6x
Unified AI Score
31.5 / 100 SELL
Tech 50.0 Fund 29.0 Flow 51.0 Mom 44.0
BSX NYSE
Boston Scientific Corp.
Surgical & Medical Instruments & Apparatus
$43.74
-1.35% 1D
Market Cap $64.1B
1M Return -1.46%
1Y Return -58.33%
Forward P/E 14.2x
Unified AI Score
58.8 / 100 HOLD
Tech 49.0 Fund 58.0 Flow 68.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EW +23.86% BSX -58.33% Spread: +82.19 pp (EW Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period EW Revenue BSX Revenue EW Op. Margin BSX Op. Margin Margin Edge
FY2018 $3.72B $9.82B 20.1% 15.3% EW
FY2019 $4.35B $10.7B 26.4% 14.1% EW
FY2020 $4.39B $9.91B 20.5% -0.8% EW
FY2021 $5.23B $11.9B 32.3% 10.1% EW
FY2022 $4.46B $12.7B 33.6% 13.0% EW
FY2023 $5.01B $14.2B 26.1% 16.5% EW
FY2024 $5.44B $16.8B 25.3% 15.5% EW
FY2025 $6.07B $20.1B 20.8% 18.0% EW

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EW (4) vs BSX (6)
Institutional Metric EW BSX Criterion Row Winner
Market Capitalization Scale $60.8B $64.1B Larger Scale BSX
Trailing P/E Ratio Valuation 61.5x 18.6x Lower Multiple BSX
Forward P/E Ratio Valuation 31.6x 14.2x Lower Multiple BSX
Revenue Growth (YoY) Growth +10.5% +1.4% Higher Growth EW
Operating Margin (TTM) Profitability 28.8% 19.6% Higher Margin EW
Net Profit Margin Profitability 15.3% 16.6% Higher Margin BSX
Return on Equity (ROE) Capital Efficiency 9.3% 14.1% Higher ROE BSX
52-Week Range Position Momentum 96% ($75โ€“$108) 6% ($40โ€“$106) Stronger Trend EW
Beta / 30D Volatility Risk Regime 0.44ฮฒ ยท 24% Vol 0.32ฮฒ ยท 45% Vol Lower Realized Risk EW
Unified Institutional Score Composite Signal 31.5 / 100 (SELL) 58.8 / 100 (HOLD) Higher Composite BSX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EW vs BSX Buy Guide
EW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 34th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BSX CONSOLIDATION
62d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live BSX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EW nor BSX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.